A biopharmaceutical company focused on developing innovative CAR T-cell therapies for hematologic malignancies and solid tumors, leveraging an integrated cell therapy platform that includes target discovery, antibody development, clinical trials, and manufacturing. The company aims to improve safety, efficacy, and cost-effectiveness of CAR T-cell treatments for cancer patients globally.